GenMark Diagnostics to Present at the William Blair 35th Annual Growth Stock Conference
May 27 2015 - 4:13PM
Business Wire
GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of
automated, multiplex molecular diagnostic testing systems,
announced today that Hany Massarany, President and Chief Executive
Officer, will present at the William Blair 35th Annual Growth Stock
Conference to be held in Chicago, Illinois at the Four Seasons
Hotel on Wednesday, June 10, 2015 at 3:20 p.m. Central Time. The
presentation will be made available at http://ir.genmarkdx.com.
ABOUT GENMARK DIAGNOSTICS
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of
automated, multiplex molecular diagnostic testing systems that
detect and measure DNA and RNA targets to diagnose disease and
optimize patient treatment. Utilizing GenMark’s proprietary
eSensor® detection technology, GenMark’s eSensor XT-8TM system is
designed to support a broad range of molecular diagnostic tests
with a compact, easy-to-use workstation and self-contained,
disposable test cartridges. The eSensor detection technology is
also incorporated into GenMark’s sample-to-answer system, ePlexTM.
For more information, visit www.genmarkdx.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150527006575/en/
GenMark Diagnostics, Inc.Hany MassaranyPresident, Chief
Executive Officer760-448-4358
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Mar 2024 to Apr 2024
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Apr 2023 to Apr 2024
